期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

药物洗脱支架再狭窄 被引量：4

下载PDF
导出
摘要 药物洗脱支架（drug eluting stent,DES）通过在冠状动脉局部持续缓慢释放抗增殖药物来抑制新生内膜形成。与金属裸支架（bare metal stent,BMS）相比,DES再狭窄发生率由20％-30％降至10％以下。
作者 宋莉 颜红兵
机构地区 阜外心血管病医院
出处 《中国介入心脏病学杂志》 2011年第5期279-282,共4页 Chinese Journal of Interventional Cardiology
关键词 药物洗脱支架 支架再狭窄 STENT 新生内膜形成 抗增殖药物 金属裸支架 冠状动脉 发生率
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献11

  • 1Hong MK, Mintz GS, Lee CW, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stentimplantation. Eur Heart J, 2006,27 : 1305-1310. 被引量：1
  • 2Fujii K,Mintz GS, Kobayashi Y, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation, 2004, 109: 1085 -1088. 被引量：1
  • 3Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation, 2006,113 : 414- 419. 被引量：1
  • 4Balakrishnan B, Tzafriri AR, Seifert P, et al. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation, 2005,111 : 2958- 2965. 被引量：1
  • 5Tagliareni F, La Manna A, Saia F, et al. Long-term clinical follow-up of dmg-eluting stent restenosis treatment: retrospective analysis from two high volume catheterization laboratories. Euro Intervention, 2010,5:703-708. 被引量：1
  • 6Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxelcoated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation, 2009,119 : 2986-2994. 被引量：1
  • 7Holmes DR Jr, Teirstein P, Satler L, et al. Sirolimus-elutingstents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA, 2006,295 : 1264 -1273. 被引量：1
  • 8Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the " real world ": the Rapamycin- Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation, 2004,109 : 190-195. 被引量：1
  • 9Zahn R, Hamm CW, Schneider S, et al. Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimuseluting coronary stent ( results from the prospective multicenter German Cypher Stent Registry ). Am J Cardiol, 2005,95 : 1302-1308. 被引量：1
  • 10Corbett'SJ,Cosgrave J, Melzi G, et al. Patterns of restenosis after drug-eluting stent implantation : insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. Eur Heart J,2006,27:2330-2337. 被引量：1

二级参考文献4

共引文献9

同被引文献60

  • 1孔令燕,金征宇,王怡宁,宋兰,张竹花,张立仁,张抒扬,林松柏,王沄,赵文敏.64层螺旋CT冠状动脉成像评价冠状动脉支架通畅性[J].中国医学科学院学报,2006,28(1):32-35. 被引量：44
  • 2解金红,李靖,关怀敏.冠状动脉支架内再狭窄相关因素研究[J].中国医师杂志,2006,8(11):1505-1506. 被引量：3
  • 3于淑靖,李忠信,马国军.64MSCT对冠状动脉支架通畅性评价的准确性与支架材料的关系[J].中国临床医学影像杂志,2007,18(10):716-718. 被引量：8
  • 4Serruys PW,Degertekin M,Tanabe K. Intravascular ultrasound findings in the multicenter,randomized,double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity bal oon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial[J].{H}CIRCULATION,2002,(07):798-803. 被引量：1
  • 5Holmes DR Jr,Leon MB,Moses JW. Analysis of 1-year clinical outcomes in the SIRIUS trial:a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis[J].{H}CIRCULATION,2004,(05):634-640. 被引量：1
  • 6Schofer J,Schluter M,Gershlick AH. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in smal coronary arteries:double-blind,randomised control ed trial (E-SIRIUS)[J].{H}LANCET,2003,(9390):1093-1099. 被引量：1
  • 7El is SG,Colombo A,Grube E. Incidence,timing,and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent:a TAXUS II,IV,V,and VI meta-analysis of 3445 patients fol owed for up to 3 years[J].{H}Journal of the America College of Cardiology,2007,(10):1043-1051. 被引量：1
  • 8Kelbaek H,Helqvist S,Thuesen L. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions:subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial[J].{H}American Heart Journal,2006,(05):882-886. 被引量：1
  • 9Rahel BM,Laarman GJ,Kelder JC. Three-year clinical outcome after primary stenting of total y occluded native coronary arteries:a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Total y Occluded Native Coronary Arteries [PRISON]II study)[J].{H}American Heart Journal,2009,(01):149-155. 被引量：1
  • 10Hong MK,Mintz GS,Lee CW. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries:a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT)[J].{H}CIRCULATION,2003,(04):517-520. 被引量：1

引证文献4

二级引证文献17

中国介入心脏病学杂志
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部